文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

早期复苏方案对脓毒症低血压成人院内死亡率的影响:一项随机临床试验

Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01
一句话结论在资源有限地区,脓毒症低血压成人采用早期复苏方案(含液体负荷与血管加压药)较常规治疗增加院内死亡率(48.1% vs 33.0%,RR 1.46)。

该随机临床试验在赞比亚一家1500张床位的转诊医院急诊科纳入212例脓毒症(疑似感染+≥2项全身炎症反应综合征标准)合并低血压(收缩压≤90 mmHg或平均动脉压≤65 mmHg)成人,1:1随机分为早期复苏方案组(n=107)和常规治疗组(n=105)。早期复苏方案包括静脉液体负荷并监测颈静脉压、呼吸频率和动脉血氧饱和度,使用血管加压药目标平均动脉压≥65 mmHg,血红蛋白<7 g/dL者输血;常规治疗由临床医生决定血流动力学管理。最终209例纳入分析(平均年龄36.7岁,男性56.0%,HIV阳性89.5%)。主要终点院内死亡率:方案组48.1%(51/106)vs 常规组33.0%(34/103),组间差异15.1%(95%CI 2.0%-28.3%),相对风险1.46(95%CI 1.04-2.05),P=0.03。6小时内方案组中位静脉液体量3.5 L(IQR 2.7-4.0)vs 常规组2.0 L(IQR 1.0-2.5),平均差异1.2 L(95%CI 1.0-1.5),P<0.001;方案组15例(14.2%)vs 常规组2例(1.9%)接受血管加压药,组间差异12.3%(95%CI 5.1%-19.4%),P<0.001。结论认为在资源有限地区以HIV阳性为主的脓毒症低血压成人中,早期复苏方案较常规治疗增加院内死亡率;需进一步研究在不同中低收入临床环境和人群中液

要点

  • 在资源有限地区脓毒症低血压成人中,早期复苏方案组院内死亡率48.1%(51/106)高于常规治疗组33.0%(34/103),RR 1.46(95%CI 1.04-2.05),P=0.03。
  • 早期复苏方案组6小时内中位静脉液体量3.5 L(IQR 2.7-4.0)多于常规治疗组2.0 L(IQR 1.0-2.5),平均差异1.2 L(95%CI 1.0-1.5),P<0.001。
  • 早期复苏方案组接受血管加压药比例14.2%(15例)高于常规治疗组1.9%(2例),组间差异12.3%(95%CI 5.1%-19.4%),P<0.001。
  • 研究人群为赞比亚转诊医院急诊科脓毒症合并低血压成人,HIV阳性占89.5%,平均年龄36.7岁。
  • 作者结论认为该早期复苏方案在资源有限地区增加院内死亡率,需进一步研究不同中低收入临床环境和人群中液体负荷与血管加压药的效果。

适用人群与场景

  • 赞比亚一家1500张床位转诊医院急诊科就诊的成人脓毒症患者(疑似感染+≥2项全身炎症反应综合征标准)合并低血压(收缩压≤90 mmHg或平均动脉压≤65 mmHg)。
  • 纳入时间为2012年10月22日至2013年11月11日,数据分析于2013年12月9日结束。
  • 最终分析209例,平均年龄36.7岁(SD 12.4),男性117例(56.0%),HIV阳性187例(89.5%)。

诊断标准与关键阈值

  • 脓毒症:疑似感染加上≥2项全身炎症反应综合征标准。
  • 低血压:收缩压≤90 mmHg或平均动脉压≤65 mmHg。
  • 早期复苏方案中血管加压药目标为平均动脉压≥65 mmHg。
  • 早期复苏方案中输血条件为血红蛋白水平<7 g/dL。

处置流程与药物剂量

  • 早期复苏方案组:静脉液体负荷,同时监测颈静脉压、呼吸频率和动脉血氧饱和度;使用血管加压药目标平均动脉压≥65 mmHg;血红蛋白<7 g/dL者输血。
  • 常规治疗组:由治疗临床医生决定血流动力学管理。

研究设计与关键结果

  • 研究类型:随机临床试验,纳入212例成人脓毒症合并低血压患者,1:1随机分为早期复苏方案组(n=107)和常规治疗组(n=105);3例不符合条件,209例完成研究并纳入分析。
  • 主要终点院内死亡率:早期复苏方案组48.1%(51/106)vs 常规治疗组33.0%(34/103),组间差异15.1%(95%CI 2.0%-28.3%),相对风险1.46(95%CI 1.04-2.05),P=0.03。
  • 6小时内静脉液体量:早期复苏方案组中位3.5 L(IQR 2.7-4.0)vs 常规治疗组2.0 L(IQR 1.0-2.5),平均差异1.2 L(95%CI 1.0-1.5),P<0.001。
  • 接受血管加压药:早期复苏方案组14.2%(15例)vs 常规治疗组1.9%(2例),组间差异12.3%(95%CI 5.1%-19.4%),P<0.001。

证据类型、等级与局限

  • 证据类型:随机临床试验(RCT),试验注册号clinicaltrials.gov NCT01663701。
  • 作者结论:在资源有限地区以HIV阳性为主的脓毒症低血压成人中,早期复苏方案较常规治疗增加院内死亡率。
  • 局限:作者指出需进一步研究在不同中低收入临床环境和患者人群中液体负荷与血管加压药的效果。

对床旁实践的改变

  • 在资源有限地区以HIV阳性为主的脓毒症低血压成人中,早期复苏方案(静脉液体负荷+血管加压药+血红蛋白<7 g/dL输血)较常规治疗增加院内死亡率,提示该方案在该人群中的效果与预期不同。
  • 作者认为需进一步研究在不同中低收入临床环境和患者人群中液体负荷与血管加压药的效果。

指南或共识出处

  • JAMA发表的随机临床试验:Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial(NCT01663701)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The effect of an early resuscitation protocol on sepsis outcomes in developing countries remains unknown.

OBJECTIVE: To determine whether an early resuscitation protocol with administration of intravenous fluids, vasopressors, and blood transfusion decreases mortality among Zambian adults with sepsis and hypotension compared with usual care.

DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 212 adults with sepsis (suspected infection plus ≥2 systemic inflammatory response syndrome criteria) and hypotension (systolic blood pressure ≤90 mm Hg or mean arterial pressure ≤65 mm Hg) presenting to the emergency department at a 1500-bed referral hospital in Zambia between October 22, 2012, and November 11, 2013. Data collection concluded December 9, 2013.

INTERVENTIONS: Patients were randomized 1:1 to either (1) an early resuscitation protocol for sepsis (n = 107) that included intravenous fluid bolus administration with monitoring of jugular venous pressure, respiratory rate, and arterial oxygen saturation and treatment with vasopressors targeting mean arterial pressure (≥65 mm Hg) and blood transfusion (for patients with a hemoglobin level <7 g/dL) or (2) usual care (n = 105) in which treating clinicians determined hemodynamic management.

MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality and the secondary outcomes included the volume of intravenous fluid received and receipt of vasopressors.

RESULTS: Among 212 patients randomized to receive either the sepsis protocol or usual care, 3 were ineligible and the remaining 209 completed the study and were included in the analysis (mean [SD] age, 36.7 [12.4] years; 117 men [56.0%]; 187 [89.5%] positive for the human immunodeficiency virus). The primary outcome of in-hospital mortality occurred in 51 of 106 patients (48.1%) in the sepsis protocol group compared with 34 of 103 patients (33.0%) in the usual care group (between-group difference, 15.1% [95% CI, 2.0%-28.3%]; relative risk, 1.46 [95% CI, 1.04-2.05]; P = .03). In the 6 hours after presentation to the emergency department, patients in the sepsis protocol group received a median of 3.5 L (interquartile range, 2.7-4.0 L) of intravenous fluid compared with 2.0 L (interquartile range, 1.0-2.5 L) in the usual care group (mean difference, 1.2 L [95% CI, 1.0-1.5 L]; P < .001). Fifteen patients (14.2%) in the sepsis protocol group and 2 patients (1.9%) in the usual care group received vasopressors (between-group difference, 12.3% [95% CI, 5.1%-19.4%]; P < .001).

CONCLUSIONS AND RELEVANCE: Among adults with sepsis and hypotension, most of whom were positive for HIV, in a resource-limited setting, a protocol for early resuscitation with administration of intravenous fluids and vasopressors increased in-hospital mortality compared with usual care. Further studies are needed to understand the effects of administration of intravenous fluid boluses and vasopressors in patients with sepsis across different low- and middle-income clinical settings and patient populations.

TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01663701.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Andrews B, Semler MW, Muchemwa L, et al. Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial. JAMA. 2017. PMID: 28973227. doi:10.1001/jama.2017.10913

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。